Urology for Practice, 2006, issue 2

Editorial

Zlaté hory po 10 letech

doc. MUDr. František Záťura CSc

Urolog. pro Praxi, 2006; 2: 47  

Review articles

Farmakologická léčba stresové inkontinence

MUDr. Jan Krhut

Urolog. pro Praxi, 2006; 2: 52-54  

Urinary incontinence is one of the most common medical conditions with an estimated 25 percent of the adult female population being affected. While overactive bladder is traditionally managed by pharmacotherapy, medication therapy in stress incontinence is of secondary importance. The options to clinically use alpha-adrenergic agents are limited by serious systemic adverse effects. The latest knowledge on physiology and pathophysiology of neural control of the closure apparatus function suggests, however, that pharmacotherapy might even be of use in this area.

New trends in the surgical treatment of benign prostatic hyperplasia - minimally invasive methods of therapy

MUDr. Martin Lukeš, MUDr. Miroslav Záleský, MUDr. Roman Zachoval Ph.D, MUDr. Jiří Heráček, MUDr. Jana Sachová, doc. MUDr. Michael Urban

Urolog. pro Praxi, 2006; 2: 56-59  

Prostatectomy is one of the most frequent urological procedures performed in the developed world. The original open surgical approach has now been replaced by transurethral techniques. Of these the transurethral resection of the prostate (TURP) is the most common and is now being considered as the gold standard for therapy of benign prostatic hyperplasia (BPH). At the turn of 20. and 21. centuries the masive and long evolution of technologies on the prostate has brought many additional therapeutic alternatives tending to the less invasive techniques. Principles, efficacy and current indications of minimally invasive therapies of BPH are reviewed.

Treatment of overactive bladder in children

MUDr. Oldřich Šmakal, MUDr. Jan Vrána, MUDr. Igor Hartmann

Urolog. pro Praxi, 2006; 2: 60-61  

In children, an overactive bladder (OAB) is characterized by polakisuria, an urgent need to urinate, sometimes accompanied by urinary incontinence. Diagnosis and therapy should be initiated after micturition control has been achieved, at the age of five by the latest. Following a basic non-invasive examination to rule out neurologic and infectious causes, complex therapy may be initiated including regimen measures, behavioural therapy, early pharmacotherapy and possibly biofeedback. When three to six months of basic therapy fail, a specialized urologic investigation and further intensive treatment using alternative methods are required.

Onkologická hlášení

Michaela Matoušková

Urolog. pro Praxi, 2006; 2: 62-64  

A comparison of clinical follow-up and therapeutic outcomes is not possible without all the specialists involved having a uniform „speech“. For oncologists, the unifying elements include the TNM classification of malignant tumours, staging classification and an effort to define the prognostic factors. The type and aggressivity of treatment are selected based on our knowledge of both the given and additional parameters. National registry databases allow for comparing data from large cohorts and thus for modifying the strategy of diagnosing and treatment in particular cases. Data collection and its quality are dependent upon a „mere“...

Sexual dysfunction after spinal cord injury

MUDr. Jiří Heráček, doc. MUDr. Michael Urban, MUDr. Vladimír Sobotka, MUDr. Martin Lukeš, MUDr. Roman Zachoval Ph.D, MUDr. Miroslav Záleský, MUDr. Lukáš Bittner

Urolog. pro Praxi, 2006; 2: 65-68  

In an overview the authors concerns in treatment options of erectile and ejaculatory dysfunctions, infertility and hypotestosteronemia in men after spinal cord injury.

Urology at a glance

Medikamentózní terapie erektilní dysfunkce

MUDr. Libor Zámečník

Urolog. pro Praxi, 2006; 2: 80-82  

Case report

Fraktura penisu u nemocného s Morbus Peyroni

MUDr. Peter Fojtík, MUDr. Karel Mainer Ph.D, MUDr. Jan Krhut, MUDr. Aleš Horák

Urolog. pro Praxi, 2006; 2: 69-70  

Endometrióza močového měchýře

MUDr. Roman Staněk, MUDr. Pavel Vágner, MUDr. Josef Palas, MUDr. Eva Sehnálková

Urolog. pro Praxi, 2006; 2: 72-74  

Malobuněčný karcinom močového měchýře

MUDr. Petr Pauk, MUDr. Pavel Pauk, MUDr. Jaroslav Beneš, doc. MUDr. Jaroslav Novák CSc

Urolog. pro Praxi, 2006; 2: 75-76  

Radikální prostatektomie a dočasná uretrostomie u psa s diagnózou adenokarcinomem prostaty a mnohočetnými uretrokutánními píštělemi

MUDr. Zbyněk Veselský Ph.D, MVDr. René Finsterle, MVDr. Vladimíra Teplá

Urolog. pro Praxi, 2006; 2: 77-79  

For nurses

Laparoskopická nebo otevřená nefrektomie - pohled sestry

Bc. Veronika Kolářová

Urolog. pro Praxi, 2006; 2: 85-87  

Information and commentaries

Jarní výjezdní pracovní konference Sdružení ambulantních urologů, Varadero, Kuba, 28. 1.-2. 2. 2006

Miroslav Hanuš

Urolog. pro Praxi, 2006; 2: 89-90  


Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.